In a word, this study preliminarily explored the mechanism of DSD on DF through network pharmacology and molecular docking technology in order to verify that the potential mechanism of DSD in treating DF may be related to the AGEs-RAGE signaling pathway and PI3K-AKT signaling pathway, reducing inflammatory reaction and increasing VEGF expression. The gene discussed is AKT1; the disease is disorder of sexual differentiation.